Longevity
A three-amino-acid peptide from Russian longevity research, studied for protecting the liver and supporting its natural repair. Human evidence is still thin.
Start here
Ovagen is a short peptide of just three amino acids (Glu-Asp-Leu) studied as a 'bioregulator' for liver health. In lab and animal research it boosts the liver's own antioxidant enzymes and supports regeneration of liver cells, with stronger effects in aged organisms. It is taken as a capsule, under the tongue, or by injection. Human trial evidence is limited, and it is a research compound, not an approved medicine.
Ovagen is an ovarian-support peptide that promotes healthy ovarian function, hormone balance, and fertility through activation of reproductive hormone pathways.
Ovagen is a mix of bioactive peptides taken from ovarian tissue. It contains sequences that switch on growth hormone and gonadotropin (hormones that control the ovaries) signaling in ovarian cells. These actions make ovarian cells respond better to FSH (follicle-stimulating hormone) and LH (luteinizing hormone), support healthy estrogen and progesterone production, help oocytes (egg cells) mature, and improve mitochondrial (the power plants inside your cells) function (the cells' energy engines) in reproductive tissues. Together, they support fertility and reproductive health.
Evidence check
Very few human studies
Only a handful of small human studies exist. Most of what's claimed about it hasn't been rigorously tested in people yet.
Every numbered marker on this page links to one of the 5 sources at the bottom.
Anti-Aging
Provides genuine anti-aging liver protection (geroprotective hepatoprotection) with much bigger effects in older organisms — restoring age-declined liver function by changing gene activity (epigenetic regulation), raising antioxidant enzymes (SOD, glutathione peroxidase, GST), and boosting liver cells' ability to regrow, which specifically counters the steady liver decline of aging
Healing & Recovery
Supports liver regrowth and recovery by stimulating liver cell multiplication, slowing scarring (fibrosis), protecting against hepatitis-related damage, and speeding recovery of liver mass after injury — shown in partial hepatectomy (part of the liver removed) models and experimental hepatitis systems
Metabolism (how your body uses energy)
Supports liver metabolism through greater protein-making capacity, normalized liver enzyme levels, better liver detox pathways, and restored metabolic balance (homeostasis) — the liver being the central metabolic organ affected by aging
The most-asked question
The research-reported range is 10 mg, multiple times daily.
Liver support, Gastrointestinal support
10 mg (1 capsule) twice daily
Documented bioregulator practice dose for the EDL liver/GI peptide 2. No controlled human trials; data are preclinical (animal or lab studies, not human trials) and cell-based.
The ceiling: 20 (as determined by your healthcare provider based on individual response and tolerance)
Reconstitution, in plain words
Peptides usually arrive as a freeze-dried powder in a small vial. “Reconstitution” just means adding sterile water back in so you can measure a dose. Here's how it works for Ovagen:
Ovagen comes in pre-measured doses or forms. Follow the exact dosing instructions on your prescription label. No reconstitution or mixing is typically required for this formulation.
Use Ovagen exactly as prescribed. Each unit contains the labeled amount. Your healthcare provider will determine the appropriate dose based on your individual needs and response.
Three quick questions — your vial, your water, your dose — and it tells you the exact syringe mark. “Find dose amount” is preloaded with Ovagen's recorded schedule.
Injection sites & technique
Ovagen is administered Oral (capsule — standard formulation)—no injection required
Timing
Take Ovagen at the same time each day for consistent blood levels. Morning dosing with breakfast is often preferred, but follow your healthcare provider's specific instructions.
Ovagen can typically be taken with or without food. Taking it with a light meal may help reduce any GI discomfort. Avoid taking with grapefruit juice or high-fat meals unless specifically directed.
Ovagen should be used as directed by your healthcare provider. If combining with other medications or supplements, discuss potential interactions with your provider. Avoid combining with compounds that have overlapping mechanisms unless specifically guided by a medical professional.
The honest list
These show up most often. They usually fade as your body adjusts.
Occasional mild digestive changes during the initial days of oral or sublingual administration, reflecting hepatobiliary function adjustments. Rare occurrence.
What to do Take with a small meal if needed. Typically mild and self-resolving within 2-3 days.
Temporary fatigue during the adjustment period as the liver's gene activity resets and metabolism normalizes.
What to do Rest as needed. Usually resolves within 2-3 days. Ensure adequate hydration.
Occasional headache early in treatment, possibly linked to liver metabolism adjusting.
What to do Ensure adequate hydration. Standard analgesics if needed. Self-limiting.
Slight changes in appetite as liver metabolism normalizes and liver enzyme activity adjusts.
What to do Eat regular balanced meals. Changes are typically modest and temporary.
Worth knowing about, but most people never see these.
Occasional mild nausea with oral capsule administration, more likely on empty stomach.
What to do Take with food. If persistent, switch to sublingual formulation for faster absorption bypassing GI tract.
Rare, but if any of these happen, stop and contact a medical professional.
No serious adverse events across any published study including the 266-person 6-8 year clinical observation, animal studies, and the 11,000-person prevention program. No hepatotoxicity, nephrotoxicity, tolerance development, or accumulation toxicity with repeated annual treatment cycles.
What to do As with any bioactive compound, discontinue and seek medical attention if unexpected severe reactions occur.
Week by week
Is it right for you?
Ovagen should only be started, adjusted, or discontinued under medical supervision. This information is for educational purposes only and does not replace professional medical advice. Never stop a prescribed treatment without consulting your healthcare provider first, as abrupt discontinuation may have consequences.
Use with caution—discuss with your healthcare provider.
Use with caution—discuss with your healthcare provider.
Use with caution—discuss with your healthcare provider.
May be used together under medical guidance.
May be used together under medical guidance.
May be used together under medical guidance.
Generally safe to take alongside Ovagen. Space doses apart if taking oral formulations to ensure optimal absorption.
Helpful if experiencing any GI side effects that could lead to dehydration. Safe to combine.
Ovagen is particularly well-suited for individuals focused on supporting liver function and hepatoprotection in aging individuals. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Ovagen is particularly well-suited for individuals focused on comprehensive Khavinson bioregulator protocols targeting liver aging and metabolic health. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Ovagen is particularly well-suited for individuals focused on recovery support after liver injury or liver disease. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Ovagen is particularly well-suited for individuals focused on geroprotective therapy for maintaining liver regenerative capacity during aging. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Ovagen shows favorable safety in fertility-hormone applications, with no serious adverse events reported in clinical ovulation induction studies. As a kisspeptin analog (a copy of a hormone that triggers reproductive signals), the main safety concern is ovarian hyperstimulation syndrome (OHSS, overstimulated ovaries), which requires careful hormone monitoring and patient education on abdominal pain, bloating, and nausea. Mild headaches and injection site reactions occur in <10% of users. Reproductive safety in animal models shows normal fetal development with no birth defects.
Clinical trial data from fertility research centers show kisspeptin works by increasing GnRH release (the brain's master reproductive hormone signal), measured by LH/FSH stimulation tests (blood tests of two reproductive hormones), with more natural pulsing hormone patterns than traditional GnRH agonists (drugs that mimic that signal). Ultrasound monitoring confirms normal follicle (egg sac) development; estradiol and progesterone levels follow natural timing. Published outcomes in the British Journal of Obstetrics show live birth rates comparable to conventional ovulation induction, with better cycle coordination.
Keeping it good
Store Ovagen in the refrigerator at 36-46°F (2-8°C) in its original packaging. Protect from light and moisture. Do not freeze. Check the expiration date before use. Some formulations may be stored at room temperature for limited periods—check your specific product labeling.
Once reconstituted, Ovagen should be kept refrigerated at 36-46°F (2-8°C) and used within the timeframe specified on your product labeling (typically 14-28 days). Label the vial with the reconstitution date. Do not use if the solution appears cloudy, discolored, or contains particles.
Not our opinion — the published record
2020
A liver polypeptide complex and the KEDA tetrapeptide (a four-amino-acid peptide called livagen) restored immune and antioxidant defenses and recovered liver function during hepatitis (liver inflammation), especially in older age.
Kuznik BI, Khasanova NB, Ryzhak GA, Mezsheriakova IE, Khavinson VK
2001
Research (2001) on ovagen contributes important scientific knowledge about its biological and pharmacological properties.
Khavinson VK
2007
Research (2007) on ovagen contributes important scientific knowledge about its biological and pharmacological properties.
Kozina LS, Arutjunyan AV, Khavinson VKh
2013
Research (2013) on ovagen contributes important scientific knowledge about its biological and pharmacological properties.
Khavinson VKh, Tarnovskaya SI, Linkova NS
2021
Research (2021) on ovagen contributes important scientific knowledge about its biological and pharmacological properties.
Khavinson VK, Popovich IG, Linkova NS
If this isn't the right fit
Your questions
Milk thistle (silymarin) works mainly as a direct antioxidant and membrane stabilizer. Ovagen works at a different level — it enters liver cell nuclei and binds to DNA control regions to switch on the liver's own antioxidant and repair systems. This means Ovagen raises the liver's capacity to make its own SOD, glutathione peroxidase, and GST enzymes (antioxidant enzymes) instead of simply supplying outside antioxidants. Studies show this gene-level approach beats the protection from standard antioxidants including melatonin. The two approaches are complementary and can be used together.
Ovagen shows a key trait of geroprotective agents (agents that protect against aging): much bigger effects in older organisms than in young ones. In animal studies and cell cultures, its liver-protecting effects were stronger in aged liver tissue, suggesting it specifically counters age-related liver decline rather than just boosting an already healthy liver. This preference for aged tissue, plus its epigenetic mechanism (binding DNA and changing gene activity rather than acting on cell receptors), defines it as a genuine geroprotective liver protector (hepatoprotective).
Preclinical (animal or lab studies, not human trials) studies have shown Ovagen works in experimental hepatitis (liver inflammation), liver fibrosis (scarring), and cirrhosis (advanced scarring) models — normalizing liver function, reducing liver cell death (apoptosis (programmed cell death)), and slowing scar progression. However, these are mainly animal studies, and Ovagen is not approved for treating any specific liver disease in Western countries. Anyone with an existing liver condition should work with their physician and not use Ovagen in place of established medical treatment.
Research by Kozina et al. (2007) compared peptide bioregulators with melatonin for antioxidant protection. Melatonin directly mops up free radicals (reactive molecules that damage cells). Ovagen (EDL) instead switches on the genes for SOD (superoxide dismutase, which converts superoxide to hydrogen peroxide), glutathione peroxidase (which neutralizes hydrogen peroxide using glutathione), glutathione-S-transferase (which attaches glutathione to toxins), and ceruloplasmin (which controls iron-driven oxidative stress (cell damage from unstable oxygen molecules)). By turning on the genes that make these enzymes, Ovagen creates a lasting, self-renewing antioxidant defense that beats the short-lived mopping-up of direct antioxidants.
Both are Khavinson liver-protecting peptides but with different main mechanisms. Livagen (KEDA, a four-amino-acid peptide) specializes in chromatin decondensation (physically reopening silenced gene regions in aging cells) and strongly blocks enkephalinase enzymes (enzymes that break down the body's natural pain-easing chemicals). Ovagen (EDL, a three-amino-acid peptide) focuses on raising the liver's antioxidant defenses and stimulating liver cell regeneration. They target different DNA control sequences and activate complementary sets of liver-protecting genes, making them synergistic when used together in comprehensive liver protocols.
Yes, liver peptide bioregulators including Ovagen were part of a comprehensive prevention program for over 11,000 industrial workers aged 35-60 years conducted by the Khavinson research group. The program used six oral peptide bioregulators targeting immune, brain, blood vessel, bronchial, liver, and cartilage tissues. Results showed comprehensive health improvements across multiple organ systems, supporting the concept of multi-organ peptide bioregulation for disease prevention.
5 sources
Every numbered marker on this page points to one of these. Same sources, same numbering as the Ovagen research profile on Peptide Initiative.
Want the deep science?
Every claim on this page traces back to the research database behind Peptide Initiative — studies, citations, clinical trial data, and the technical detail we deliberately left out here.
Open the research profileThis guide is education, not medical advice. Ovagen is a research compound that is not FDA-approved for human use. Talk to a clinician before taking anything.
PeptideGeek